Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G E Bigelow

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
British Journal of Addiction|December 1, 1991
Human drug abuse liability assessment: opioids and analgesicsG E Bigelow
NIDA Research Monograph|July 1, 1978
Drug abuse research in outpatient clinicsM Stitzer, G E Bigelow
Behavioural Pharmacology|December 23, 1998
Opioid discrimination in humans: discriminative and subjective effects of progressively lower training doseK L Preston, G E Bigelow
NIDA Research Monograph|January 1, 1989
Drug discrimination: methods for drug characterization and classificationG E Bigelow, K L Preston
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discriminationK L Preston, G E Bigelow
NIDA Research Monograph|January 1, 1991
Factors influencing assessment of opioid miosis in humansL L Weinhold, G E Bigelow
Drug and Alcohol Dependence|April 1, 1992
Validity of patients' self-reported drug use as a function of treatment statusM F Sherman, G E Bigelow
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteersK L Preston, G E Bigelow
Journal of Applied Behavior Analysis|January 1, 1984
Contingent reinforcement for carbon monoxide reduction: within-subject effects of pay amountM L Stitzer, G E Bigelow
Addictive Behaviors|January 1, 1982
Contingent reinforcement for reduced carbon monoxide levels in cigarette smokersM L Stitzer, G E Bigelow
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
British Journal of Addiction|December 1, 1991
Human drug abuse liability assessment: opioids and analgesicsG E Bigelow
NIDA Research Monograph|July 1, 1978
Drug abuse research in outpatient clinicsM Stitzer, G E Bigelow
Behavioural Pharmacology|December 23, 1998
Opioid discrimination in humans: discriminative and subjective effects of progressively lower training doseK L Preston, G E Bigelow
NIDA Research Monograph|January 1, 1989
Drug discrimination: methods for drug characterization and classificationG E Bigelow, K L Preston
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discriminationK L Preston, G E Bigelow
NIDA Research Monograph|January 1, 1991
Factors influencing assessment of opioid miosis in humansL L Weinhold, G E Bigelow
Drug and Alcohol Dependence|April 1, 1992
Validity of patients' self-reported drug use as a function of treatment statusM F Sherman, G E Bigelow
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1993
Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteersK L Preston, G E Bigelow
Journal of Applied Behavior Analysis|January 1, 1984
Contingent reinforcement for carbon monoxide reduction: within-subject effects of pay amountM L Stitzer, G E Bigelow
Addictive Behaviors|January 1, 1982
Contingent reinforcement for reduced carbon monoxide levels in cigarette smokersM L Stitzer, G E Bigelow
Pageof 20